The Effect of Continuous Blood Purification on the Prognosis of Cardiorenal Syndrome Patients

详细信息    查看全文

• 作者：Fengyu Jia ; Peng Rong ; Dandan Li ; Suxia Wang ; Ying Jing…
• 关键词：Renal dialysis ; Heart failure ; Kidney injury
• 刊名：Cell Biochemistry and Biophysics
• 出版年：2015
• 出版时间：March 2015
• 年：2015
• 卷：71
• 期：2
• 页码：957-961
• 全文大小：172 KB
• 参考文献：1. Du, Y., Li, X., & Liu, B. (2014). Advances in pathogenesis and current therapeutic strategies for CRS. / Life Sciences, / 99(1-), 1-. CrossRef
  2. Kociol, R., Rogers, J., & Shaw, A. (2009). Organ cross talk in the critically ill: the heart and kidney. / Blood Purification, / 27(4), 311-20. CrossRef
  3. Lindner, G., Doberer, E., Vychytil, A., et al. (2009). Prognosis in patients with congestive heart failure and subacute renal failure treated with hemodialysis. / Wiener klinische Wochenschrift, / 121(11-2), 391-97. CrossRef
  4. Li, X., Mao, H., Yu, X., et al. (2014). Prognostic factors in continuous hemofiltration therapy for patients with CRS. / Blood Purification, / 37(2), 99-05. CrossRef
  5. Ricci, Z., & Ronco, C. (2012). Renal replacement therapy in the critically ill:getting it right. / Current Opinion in Critical Care, / 18(6), 607-12. CrossRef
  6. Lee, P. T., Lin, H. H., Jiang, S. T., et al. (2010). Mouse kidney progenitor cells accelerate renal regeneration and prolong survival after ischemic injury. / Stem Cells, / 28(3), 573-84.
  7. Dunlay, S. M., Pereira, N. L., & Kushwaha, S. S. (2014). Contemporary strategies in the diagnosis and management of heart failure. / Mayo Clinic Proceedings, / 89(5), 662-76. CrossRef
  8. Ronco, C. (2005). Acute Dialysis Quality Initiative (ADQI): the PASSPORT project. / International Journal of Artificial Organs, / 28(5), 438-40.
  9. Fieghen, H., Wald, R., & Jaber, B. L. (2009). Renal replacement therapy for AKI. / Nephron Clinical Practice, / 112(4), c222–c229. CrossRef
  10. Ronco, C., Chionh, C. Y., Haapio, M., Anavekar, N. S., House, A., & Bellomo, R. (2009). The cardiorenal syndrome. / Blood Purification, / 27(1), 114-26. CrossRef
  11. Shlipak, M. G. (2003). Pharmacotherapy for heart failure in patients with renal insufficiency. / Annals of Internal Medicine, / 138(11), 917-24. CrossRef
  12. Jarnberg, P. O. (2004). Renal protection strategies in the perioperative period. / Best Practice & Research Clinical Anaesthesiology, / 18(4), 645-60. CrossRef
  13. Wago, M., & Shimooka, T. (2011). Extracorporeal blood purification (renal replacement therapy). / Nihon Rinsho, / 69(3), 534-40.
  14. Kaltenmaier, B., Pommer, W., Kaufmann, F., Hennig, E., Molzahn, M., & Hetzer, R. (2000). Outcome of patients with ventricular assist devices and acute renal failure requiring renal replacement therapy. / ASAIO Journal, / 46(3), 330-33. CrossRef
  15. Jang, H. R., Gandolfo, M. T., Ko, G. J., Satpute, S. R., Racusen, L., & Rabb, H. (2010). B cells limit repair after ischemic AKI. / Journal of the American Society of Nephrology, / 21(4), 654-65. CrossRef
  
• 刊物主题：Biochemistry, general; Pharmacology/Toxicology; Biotechnology; Cell Biology; Biophysics and Biological Physics;
• 出版者：Springer US
• ISSN：1559-0283

文摘

To discuss the effect of continuous blood purification (CBP) on the prognosis of cardiorenal syndrome (CRS) patients. Twenty-seven patients were selected for this study, who had previously been treated at the Blood Purification Center of the General Hospital of Jinan Military Region from May 2007 to October 2010. All patients suffered from chronic heart failure and acute kidney injury. Using a non-invasive hemodynamics monitoring system, we observed the dynamic changes in their cardiac output (CO), systemic vascular resistance (SVR), thoracic fluid capacity (TFC), central venous pressure (CVP), urinary volume, and Acute Physiology and Chronic Health Evaluation II system (APACHEII) score. Individual measurements were obtained at 24?h, 48?h, 72?h, 96?h, and 120?h after CBP treatment. At the same time, levels of serum creatinine (Scr), cysteine proteinase inhibitor Cystatin C (CysC), high sensitivity C-reactive protein (hs-CRP), and serum sodium were observed. The fatality rate at 28?days was also recorded. After 24?h of CBP treatment, acidosis, CO, and disturbances in water and electrolyte levels were all improved. As well, concentrations of Scr and CysC were significantly decreased, and the levels of SVR, TFC, and CVP were also decreased. After 72?h of CBP treatment, hs-CRP levels and APACHE II scores were significantly lower (P?